Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

China flag China · Delayed Price · Currency is CNY
34.00
+0.26 (0.77%)
Mar 20, 2026, 3:04 PM CST
Market Cap3.60B +25.5%
Revenue (ttm)1.10B +11.9%
Net Income120.51M +4.0%
EPS1.15 +6.6%
Shares Out105.91M
PE Ratio29.57
Forward PEn/a
Dividend0.20 (0.59%)
Ex-Dividend Daten/a
Volume4,937,302
Average Volume3,709,490
Open33.20
Previous Close33.74
Day's Range33.20 - 34.97
52-Week Range24.05 - 42.88
Beta-0.26
RSI44.00
Earnings DateApr 28, 2026

About SHE:002864

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd was founded in 1997 and is based in Xi'an, China. [Read more]

Sector Healthcare
Founded 1997
Employees 933
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002864
Full Company Profile

Financial Performance

In 2024, SHE:002864's revenue was 973.86 million, a decrease of -0.71% compared to the previous year's 980.83 million. Earnings were 120.27 million, an increase of 8.91%.

Financial Statements